MedImpact expands access and affordability across healthcare with a low-cost alternative to one of the most prescribed and expensive biologics in the US MedImpact Holdings, Inc. today announced the ...
The Adalimumab Injection Market encompasses the global industry involved in manufacturing, distributing, and deploying adalimumab-based biologic therapies. These injections are primarily used to treat ...
(RTTNews) - Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, said its Adalimumab Injection 9MW0113, marketed as JUNMAIKANG in China, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results